Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuang Wei
Observed names:
Y. Wei,
Yu‐Ang Wei
Institution:
Shanghai University of Traditional Chinese Medicine
Observed institutions:
Shanghai University of Traditional Chinese Medicine,
Shuguang Hospital,
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0000-0001-6282-1136
Observed ORCID:
0000-0001-6282-1136
OpenAlex ID:
A5005449734
AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma
2022
·
Yingqing Liu
, Jiawei Wang
, et al.
·
Scientific Reports
·
139
PDF
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
2021
·
Yuang Wei
, Xinglin Chen
, et al.
·
Frontiers in Genetics
·
83
PDF
Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients
2022
·
Dong Zhang
, Xinchi Xu
, et al.
·
Cancer Control
·
60
Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
2022
·
Bao Wang
, Qiang Song
, et al.
·
Frontiers in Immunology
·
28
Programmed Cell Death in Cancer
2025
·
Yuang Wei
, William Hankey
, et al.
·
MedComm
·
23
PDF
Environmental explanation of prostate cancer progression based on the comprehensive analysis of perfluorinated compounds
2023
·
Yuang Wei
, Haibing He
, et al.
·
Ecotoxicology and Environmental Safety
·
15
CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
2024
·
Can Chen
, Jia Xu
, et al.
·
Cancer Medicine
·
10
Essential m6A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma
2022
·
Jiajin Wu
, Yuang Wei
, et al.
·
Journal of Oncology
·
10
PDF
A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts
2022
·
H. Xu
, H. Zheng
, et al.
·
Clinical Oncology
·
8
CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling
2023
·
Xinglin Chen
, Tongtong Zhang
, et al.
·
European journal of medical research
·
7
PDF
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1
2026
·
Xuehui Li
, Siliang Wang
, et al.
·
Proceedings of the National Academy of Sciences
·
4
Mapping the application landscape of artificial intelligence in prostate cancer: a global bibliometric analysis
2025
·
Yuang Wei
, Zubing Mei
, et al.
·
International Journal of Surgery
·
4
Saikosaponin‑D triggers cancer cell death by targeting the PIM1/c-Myc axis to reprogram oncogenic alternative splicing
2025
·
Xin Zhang
, Xuehui Li
, et al.
·
Cell Death Discovery
·
3
Castration-resistant prostate cancer as an adaptive tumor ecosystem: coupling tumor evolution with microenvironmental reprogramming
2026
·
Siliang Wang
, Xinyi Xu
, et al.
·
Cancer and Metastasis Reviews
[Correlation between methylation of interferon regulatory factor 6 gene promoter in renal tissues and overall survival of patients with Kidney renal clear cell carcinoma].
2024
·
Jiexin Zhang
, Can Chen
, et al.
·
PubMed
Development of a Novel KCNN4‐Related ceRNA Network and Prognostic Model for Renal Clear Cell Carcinoma
2023
·
Hengtao Bu
, Qiang Song
, et al.
·
Analytical Cellular Pathology
PDF
Prognostic role of DDR genes mutations and their association with the sensitivity of Olaparib in prostate cancer patients
2021
·
Xinglin Chen
, Dong Zhang
, et al.
PDF
Show more works
View as search
Works count:
17
Citation count:
394
H-index:
8
I10-index:
8
Year
Topic
Type